Device Trial Radar · NCT00885677
MOnitoring REsynchronization deviCes and cARdiac patiEnts
Last checked: Nov 20, 2026Latest source record: Jul 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
918
Actual
Start
Jun 2009
Primary completion
Dec 2015
Study completion Jan 2016
Sponsor
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
- Sponsor type
- Industry
- First posted
- Apr 22, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to compare two different strategies of disease management in heart failure patients treated with cardiac resynchronization therapy devices 1. Remote monitoring with CareLink Network System 2. Standard management of the disease by means of scheduled routine in-patient follow-ups; and to demonstrate that the remote monitoring strategy is superior to the standard strategy, both in terms of clinical effectiveness and total healthcare system utilization.
Conditions
- Heart Failure
Interventions
Medtronic CareLink® NetworkDevice
Continuous monitoring via a disease remote management system. Patients of the Study group will receive a remote monitor and their device will be programmed to have wireless telemetry, Care Alerts, and the ability to transmit over the Medtronic CareLink® network. Clinical and device conditions will be then monitored continuously and alarms for the physician will be generated if a set of pre-defined potentially harming conditions should occur.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1: Median Time Between Event Onset Time and Clinical Decision for Each Subject.Time frame: 1 year since the randomization
- Phase 2: Combined Endpoint of Death From Any Cause, Cardiovascular and Device-related Hospitalizations (at Least 48 Hours Stay), Calculated as Number of Subjects With at Least One EventTime frame: 2 years after randomization
Locations
64 sites in 10 countries. Site status is shown where the registry gives one.
Institut Klinicke a Experimentalni Mediciny
Prague, Czechia
Centre Hospitalier Universitaire de Angers
Angers, France
Hôpital Cardiologique du Haut Lévêque
Bordeaux, France
61 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.